Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.

Phillips GD, Fields CT, Li G, Dowbenko D, Schaefer G, Miller K, Andre F, Burris HA 3rd, Albain KS, Harbeck N, Dieras V, Crivellari D, Fang L, Guardino E, Olsen SR, Crocker LM, Sliwkowski MX.

Clin Cancer Res. 2014 Jan 15;20(2):456-68. doi: 10.1158/1078-0432.CCR-13-0358. Epub 2013 Oct 4.

2.

PPM1H is a p27 phosphatase implicated in trastuzumab resistance.

Lee-Hoeflich ST, Pham TQ, Dowbenko D, Munroe X, Lee J, Li L, Zhou W, Haverty PM, Pujara K, Stinson J, Chan SM, Eastham-Anderson J, Pandita A, Seshagiri S, Hoeflich KP, Turashvili G, Gelmon KA, Aparicio SA, Davis DP, Sliwkowski MX, Stern HM.

Cancer Discov. 2011 Sep;1(4):326-37. doi: 10.1158/2159-8290.CD-11-0062. Epub 2011 Jul 20.

3.

A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies.

Schaefer G, Haber L, Crocker LM, Shia S, Shao L, Dowbenko D, Totpal K, Wong A, Lee CV, Stawicki S, Clark R, Fields C, Lewis Phillips GD, Prell RA, Danilenko DM, Franke Y, Stephan JP, Hwang J, Wu Y, Bostrom J, Sliwkowski MX, Fuh G, Eigenbrot C.

Cancer Cell. 2011 Oct 18;20(4):472-86. doi: 10.1016/j.ccr.2011.09.003.

4.

The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor.

Tang TT, Dowbenko D, Jackson A, Toney L, Lewin DA, Dent AL, Lasky LA.

J Biol Chem. 2002 Apr 19;277(16):14255-65. Epub 2002 Jan 2.

5.

AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival.

Li Y, Dowbenko D, Lasky LA.

J Biol Chem. 2002 Mar 29;277(13):11352-61. Epub 2001 Dec 27.

6.

ALCAM (CD166): its role in hematopoietic and endothelial development.

Ohneda O, Ohneda K, Arai F, Lee J, Miyamoto T, Fukushima Y, Dowbenko D, Lasky LA, Suda T.

Blood. 2001 Oct 1;98(7):2134-42.

PMID:
11568000
7.

PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase.

Wu Y, Dowbenko D, Pisabarro MT, Dillard-Telm L, Koeppen H, Lasky LA.

J Biol Chem. 2001 Jun 15;276(24):21745-53. Epub 2001 Mar 2.

8.

Caenorhabditis elegans PIAK, a phospholipid-independent kinase that activates the AKT/PKB survival kinase.

Li Y, Dowbenko D, Lasky LA.

J Biol Chem. 2001 Jun 8;276(23):20323-9. Epub 2001 Mar 23.

9.

Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.

Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasky LA.

J Biol Chem. 2000 Jul 14;275(28):21477-85.

10.

Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts.

Angers-Loustau A, Côté JF, Charest A, Dowbenko D, Spencer S, Lasky LA, Tremblay ML.

J Cell Biol. 1999 Mar 8;144(5):1019-31.

11.
13.

PSTPIP: a tyrosine phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase.

Spencer S, Dowbenko D, Cheng J, Li W, Brush J, Utzig S, Simanis V, Lasky LA.

J Cell Biol. 1997 Aug 25;138(4):845-60.

14.

A novel protein-tyrosine phosphatase related to the homotypically adhering kappa and mu receptors.

Cheng J, Wu K, Armanini M, O'Rourke N, Dowbenko D, Lasky LA.

J Biol Chem. 1997 Mar 14;272(11):7264-77.

15.
16.

Selective modulation of the expression of L-selectin ligands by an immune response.

Hoke D, Mebius RE, Dybdal N, Dowbenko D, Gribling P, Kyle C, Baumhueter S, Watson SR.

Curr Biol. 1995 Jun 1;5(6):670-8.

17.

Expression of GlyCAM-1, an endothelial ligand for L-selectin, is affected by afferent lymphatic flow.

Mebius RE, Dowbenko D, Williams A, Fennie C, Lasky LA, Watson SR.

J Immunol. 1993 Dec 15;151(12):6769-76.

PMID:
7505014
18.
19.

Bovine L-selectin: a peripheral lymphocyte homing receptor.

Bosworth BT, Dowbenko D, Shuster DE, Harp JA.

Vet Immunol Immunopathol. 1993 Aug;37(3-4):201-15.

PMID:
7694420
20.

Cloning of a rat homologue of mouse GlyCAM 1 reveals conservation of structural domains.

Dowbenko D, Watson SR, Lasky LA.

J Biol Chem. 1993 Jul 5;268(19):14399-403.

21.

Structure and chromosomal localization of the murine gene encoding GLYCAM 1. A mucin-like endothelial ligand for L selectin.

Dowbenko D, Andalibi A, Young PE, Lusis AJ, Lasky LA.

J Biol Chem. 1993 Feb 25;268(6):4525-9.

22.

Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates.

Nakamura GR, Byrn R, Rosenthal K, Porter JP, Hobbs MR, Riddle L, Eastman DJ, Dowbenko D, Gregory T, Fendly BM, et al.

AIDS Res Hum Retroviruses. 1992 Nov;8(11):1875-85.

PMID:
1283308
23.

An endothelial ligand for L-selectin is a novel mucin-like molecule.

Lasky LA, Singer MS, Dowbenko D, Imai Y, Henzel WJ, Grimley C, Fennie C, Gillett N, Watson SR, Rosen SD.

Cell. 1992 Jun 12;69(6):927-38.

PMID:
1376638
24.

The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide.

Foxall C, Watson SR, Dowbenko D, Fennie C, Lasky LA, Kiso M, Hasegawa A, Asa D, Brandley BK.

J Cell Biol. 1992 May;117(4):895-902.

25.

Glycosylation-dependent cell adhesion molecule 1: a novel mucin-like adhesion ligand for L-selectin.

Lasky LA, Singer MS, Dowbenko D, Imai Y, Henzel W, Fennie C, Watson S, Rosen SD.

Cold Spring Harb Symp Quant Biol. 1992;57:259-69. Review. No abstract available.

PMID:
1285051
26.

Characterization of the murine homing receptor gene reveals correspondence between protein domains and coding exons.

Dowbenko DJ, Diep A, Taylor BA, Lusis AJ, Lasky LA.

Genomics. 1991 Feb;9(2):270-7.

PMID:
2004776
27.

The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranes.

Haffar OK, Dowbenko DJ, Berman PW.

Virology. 1991 Jan;180(1):439-41.

PMID:
1984664
28.

Use of heterologous and homologous signal sequences for secretion of heterologous proteins from yeast.

Hitzeman RA, Chen CY, Dowbenko DJ, Renz ME, Liu C, Pai R, Simpson NJ, Kohr WJ, Singh A, Chisholm V, et al.

Methods Enzymol. 1990;185:421-40. No abstract available.

PMID:
2199791
29.

Cloning of a lymphocyte homing receptor reveals a lectin domain.

Lasky LA, Singer MS, Yednock TA, Dowbenko D, Fennie C, Rodriguez H, Nguyen T, Stachel S, Rosen SD.

Cell. 1989 Mar 24;56(6):1045-55.

PMID:
2647302
30.

Protein products from yeast.

Hitzeman RA, Chang CN, Chen CY, Singh A, Etcheverry T, Chisholm V, Kohr W, Vehar G, Renz M, Dowbenko D.

Biochem Soc Trans. 1988 Dec;16(6):1081. No abstract available.

PMID:
2852129
31.

Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies.

Dowbenko D, Nakamura G, Fennie C, Shimasaki C, Riddle L, Harris R, Gregory T, Lasky L.

J Virol. 1988 Dec;62(12):4703-11.

32.
33.

Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.

Lasky LA, Groopman JE, Fennie CW, Benz PM, Capon DJ, Dowbenko DJ, Nakamura GR, Nunes WM, Renz ME, Berman PW.

Science. 1986 Jul 11;233(4760):209-12.

PMID:
3014647
34.

Bacterial expression of the acquired immunodeficiency syndrome retrovirus p24 gag protein and its use as a diagnostic reagent.

Dowbenko DJ, Bell JR, Benton CV, Groopman JE, Nguyen H, Vetterlein D, Capon DJ, Lasky LA.

Proc Natl Acad Sci U S A. 1985 Nov;82(22):7748-52.

35.

Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12.

Robertson BH, Grubman MJ, Weddell GN, Moore DM, Welsh JD, Fischer T, Dowbenko DJ, Yansura DG, Small B, Kleid DG.

J Virol. 1985 Jun;54(3):651-60.

36.

Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A.

Weddell GN, Yansura DG, Dowbenko DJ, Hoatlin ME, Grubman MJ, Moore DM, Kleid DG.

Proc Natl Acad Sci U S A. 1985 May;82(9):2618-22.

37.

Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle.

McKercher PD, Moore DM, Morgan DO, Robertson BH, Callis JJ, Kleid DG, Shire SJ, Yansura DG, Dowbenko D, Small B.

Am J Vet Res. 1985 Mar;46(3):587-90.

PMID:
2986495
39.

Biochemical map of polypeptides specified by foot-and-mouth disease virus.

Grubman MJ, Robertson BH, Morgan DO, Moore DM, Dowbenko D.

J Virol. 1984 May;50(2):579-86.

40.
41.

Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein D.

Berman PW, Dowbenko D, Lasky LA, Simonsen CC.

Science. 1983 Nov 4;222(4623):524-7.

PMID:
6312563
42.

Identification of amino acid and nucleotide sequence of the foot-and-mouth disease virus RNA polymerase.

Robertson BH, Morgan DO, Moore DM, Grubman MJ, Card J, Fischer T, Weddell G, Dowbenko D, Yansura D.

Virology. 1983 Apr 30;126(2):614-23.

PMID:
6305004
43.

Immune response to human influenza virus hemagglutinin expressed in Escherichia coli.

Davis AR, Bos T, Ueda M, Nayak DP, Dowbenko D, Compans RW.

Gene. 1983 Mar;21(3):273-84.

PMID:
6343189
44.
45.

Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine.

Kleid DG, Yansura D, Small B, Dowbenko D, Moore DM, Grubman MJ, McKercher PD, Morgan DO, Robertson BH, Bachrach HL.

Science. 1981 Dec 4;214(4525):1125-9.

PMID:
6272395
46.

Expression of antigenic determinants of the hemagglutinin gene of a human influenza virus in Escherichia coli.

Davis AR, Nayak DP, Ueda M, Hiti AL, Dowbenko D, Kleid DG.

Proc Natl Acad Sci U S A. 1981 Sep;78(9):5376-80.

47.

Regulation of protein synthesis during spore germination in Dictyostelium discoideum.

Dowbenko DJ, Ennis HL.

Proc Natl Acad Sci U S A. 1980 Apr;77(4):1791-5.

48.
50.

Regulation of the hepatic synthesis of alpha2u globulin and its corresponding messenger RNA in maturing male rats.

Roy AK, Schiop MJ, Dowbenko DJ.

FEBS Lett. 1976 Nov;70(1):137-40. No abstract available.

Supplemental Content

Loading ...
Support Center